Key Developments: Bruker Corp (BRKR.O)

BRKR.O on Nasdaq

23.45USD
22 Jul 2014
Price Change (% chg)

$0.10 (+0.43%)
Prev Close
$23.35
Open
$23.41
Day's High
$23.69
Day's Low
$23.36
Volume
743,369
Avg. Vol
678,770
52-wk High
$24.93
52-wk Low
$17.44

Search Stocks

Latest Key Developments (Source: Significant Developments)

Bruker Corp announces new mass spectrometry systems and solutions for life-science research, clinical research, biopharma and applied markets
Monday, 16 Jun 2014 06:00am EDT 

Bruker Corp:Says mass spectrometry-based product introductions for life-science research and proteomics, for clinical research, for pharma/biopharma/CRO customers, as well as for applied and industrial markets.Says new systems and solutions are designed to deliver confident analyses with significantly enhanced performance, productivity and versatility.  Full Article

Bruker wins two orders for FT-NIR Spectrometers in China
Thursday, 15 May 2014 07:00am EDT 

Bruker Corp:Receives two orders of TANGO and MATRIX-I FT-NIR spectrometers from animal nutrition companies in the People's Republic of China.  Full Article

Bruker Corp reaffirms FY 2014 outlook
Wednesday, 7 May 2014 04:01pm EDT 

Bruker Corp:Maintains FY 2014 guidance.Expects FY 2014 year-over-year revenue growth of 3 to 4 pct.Expects FY 2014 non-GAAP earnings per share growth of 10 to 14 pct.Reported revenue of $1.839 bln, EPS of $0.77 in FY 2013.FY 2014 revenue of $1.908 bln, EPS of $0.87 - Thomson Reuters I/B/E/S.  Full Article

Bruker Corp gives FY 2014 outlook below analysts' estimates
Tuesday, 18 Feb 2014 04:01pm EST 

Bruker Corp:Expects FY 2014 revenue growth of about 3 to 4 pct.Expects FY 2014 non-GAAP EPS growth of 10 to 14 pct.The company reported revenue of $1.839 bln, EPS of $0.77 in FY 2013.FY 2014 revenue of $1.870 bln, EPS of $0.88 - Thomson Reuters I/B/E/S.  Full Article

Bruker Corp announces FDA clearance to market the MALDI biotyper CA system
Tuesday, 26 Nov 2013 07:00am EST 

Bruker Corp:Says it has been granted U.S. FDA clearance to market its MALDI BiotyperCA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens.  Full Article

Bruker Corp Lowers FY 2013 Guidance
Friday, 1 Nov 2013 06:00am EDT 

Bruker Corp lowered guidance for fiscal 2013 and expects revenues to decrease between -1% and breakeven percentage, compared to the full year 2012. This revised guidance implies fiscal 2013 organic revenue growth to be between breakeven percentage and 1%. Fiscal 2013 non-GAAP EPS is now expected to be in the range of $0.72 to $0.76, compared to previous expectations of $0.80 to $0.83. The Company reported revenue of $1.791 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.835 billion and EPS of $0.81 for fiscal 2013.  Full Article

Bruker Corp Announces Acquisition of Prairie Technologies
Thursday, 12 Sep 2013 04:05pm EDT 

Bruker Corp announced that it has acquired Prairie Technologies, Inc. (Prairie), a provider of life science fluorescence microscopy products. The acquisition strengthens Bruker`s position in life science markets, adding to the Bruker Nano Surfaces Division`s existing life science atomic force microscopy (Bio-AFM) systems. Bruker intends to operate Prairie Technologies as a business unit in the Madison, Wisconsin area, and plans to leverage the global marketing, distribution and service capabilities of the Bruker Nano Surfaces division.  Full Article

Bruker Corp Reaffirms FY 2013 Guidance
Wednesday, 31 Jul 2013 04:01pm EDT 

Bruker Corp announced that it is maintaining its updated financial guidance for fiscal 2013, issued on May 2, 2013. The Company expects to generate reported revenue growth of 2% to 3%. Fiscal 2013 non-GAAP EPS is expected to be in the range of $0.80 to $0.83, with a significant portion of the earnings occurring in the fourth quarter. The Company reported revenue of $1.791 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.82 billion and EPS of $0.81 for fiscal 2103.  Full Article

Bruker Corp And 3M Co Sign Exclusive Patent License Agreement
Tuesday, 4 Jun 2013 07:00am EDT 

Bruker Corp announced that it has signed an exclusive patent license agreement with 3M Co, which allows Bruker to include 3M patented innovations relating to matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging. The licensed 3M patents are directed to a technique for performing mass spectrometry analysis on proteins in tissue that has been preserved in paraffin. The technology enables researchers to more easily study formalin-fixed, paraffin-embedded (FFPE) tissue for life-science research and drug development.  Full Article

Bruker Corp Lowers FY 2013 Guidance
Thursday, 2 May 2013 04:01pm EDT 

Bruker Corp updated fiscal 2013 guidance and expects reported revenue growth rates by approximately 2% due to the recent Yen depreciation. This reduction is expected to result in reported revenue growth of 2% to 3% for fiscal 2013. The Company now expects to report fiscal 2013 non-GAAP EPS of between $0.80 and $0.83, a reduction of $0.08 from previous guidance, also due primarily to the weaker Yen. The Company reported revenue of $1.791 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $1.87 billion and EPS of $0.90 for fiscal 2103.  Full Article

Search Stocks